中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肝硬化失代偿期合并恶性胸膜间皮瘤并腹膜转移1例报告

卢利霞 谢小青 郑英 刘鑫 王建平 王俊科 王盼 于晓辉

引用本文:
Citation:

肝硬化失代偿期合并恶性胸膜间皮瘤并腹膜转移1例报告

DOI: 10.3969/j.issn.1001-5256.2022.02.030
基金项目: 

甘肃省科技厅省青年科技基金计划 (20JR10RA012)

利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:卢利霞、谢小青、郑英负责资料分析,撰写论文;王建平、王俊科、王盼负责病例收集,修改论文;刘鑫、于晓辉指导撰写文章并最后定稿。
详细信息
    通信作者:

    于晓辉,yuxiaohui528@126.com

Malignant pleural mesothelioma with peritoneal metastasis in cirrhotic decompensation: A case report

Research funding: 

Youth Science and Technology Fund Program of Gansu Provincial Department of Science and Technology (20JR10RA012)

More Information
  • 图  1  胸部CT检查

    注:右下肺门软组织影、右侧胸腔积液。a, 肺窗(箭头);b, 纵隔窗(箭头)。

    图  2  胸水脱落细胞学(HE染色,×200)

    注:细胞核大、深染,核浆比例失调。

    图  3  PET-CT检查

    注:a, 前上腹壁类圆形低密度灶(箭头); b, 右侧胸膜多发结节状增厚(箭头)。

  • [1] LOCOCO F. Malignant pleural mesothelioma: Time is running out[J]. J Clin Med, 2021, 10(4): 648. DOI: 10.3390/JCM10040648.
    [2] RINGGAARD PETERSEN T, PANOU V, MERISTOUDIS C, et al. Clinical prognostic factors in pleural mesothelioma: Best supportive care and anti-tumor treatments in a real-life setting[J]. Acta Oncol, 2021, 60(4): 521-527. DOI: 10.1080/0284186X.2021.1876246.
    [3] LETTIERI S, BORTOLOTTO C, AGUSTONI F, et al. The evolving landscape of the molecular epidemiology of malignant pleural mesothelioma[J]. J Clin Med, 2021, 10(5): 1034. DOI: 10.3390/jcm10051034.
    [4] CHANG H, YU ZY, WANG QM, et al. Clinical characteristics and diagnostic analysis of 120 cases with malignant pleural mesothelioma[J]. Tumor, 2020, 40(3): 199-205, 214. DOI: 10.3781/j.issn.1000-7431.2020.33.006.

    常浩, 余宗艳, 王启明, 等. 120例恶性胸膜间皮瘤的临床特征及诊断分析[J]. 肿瘤, 2020, 40(3): 199-205, 214. DOI: 10.3781/j.issn.1000-7431.2020.33.006.
    [5] LEE DS, CAROLLO A, ALPERT N, et al. VATS pleurectomy decortication is a reasonable alternative for higher risk patients in the management of malignant pleural mesothelioma: An analysis of short-term outcomes[J]. Cancers (Basel), 2021, 13(5): 1068. DOI: 10.3390/cancers13051068.
    [6] LOMBARD A, MISTRY H, CHAPMAN SC, et al. Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed[J]. Eur J Pharm Sci, 2021, 161(1): 105781. DOI: 10.1016/j.ejps.2021.105781.
    [7] KHALIQ MF, NOORANI MM, CHOWDHRY M, et al. Transjugular intrahepatic portosystemic shunt (TIPS) in refractory transudative chylothorax due to liver cirrhosis[J]. Case Rep Med, 2020, 2020: 2581040. DOI: 10.1155/2020/2581040.
    [8] LIU ST, LIN DD, LI J, et al. A case of hepatitis B cirrhosis complicated with malignant peritoneal mesothelioma[J]. J Infect Dis, 2017, 35(9): 565. DOI: 10.3760/cma.j.issn.0254-1432.2017.09.013.

    刘松涛, 林栋栋, 李娟, 等. 乙型肝炎肝硬化合并恶性腹膜间皮瘤一例[J]. 中华传染病杂志, 2017, 35(9): 565. DOI: 10.3760/cma.j.issn.0254-1432.2017.09.013.
    [9] WANG Y, WANG M, ZHANG GH, et al. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. J Clin Hepatol, 2021, 37(1): 17-21. DOI: 10.3969/j.issn.1001-5256.2021.01.004.

    王宇, 王民, 张冠华, 等. 肝硬化的诊断、分期及治疗原则[J]. 临床肝胆病杂志, 2021, 37(1): 17-21. DOI: 10.3969/j.issn.1001-5256.2021.01.004.
  • 加载中
图(3)
计量
  • 文章访问数:  373
  • HTML全文浏览量:  136
  • PDF下载量:  32
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-05-21
  • 录用日期:  2021-08-16
  • 出版日期:  2022-02-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回